Amendment No. 1 to Non-Disclosure AgreementNon-Disclosure Agreement • March 8th, 2011 • Clinical Data Inc • Pharmaceutical preparations
This Amendment No. 1 to Non-Disclosure Agreement (this “Amendment”), dated as of May 6, 2010, is entered into by and between Clinical Data, Inc. (“Disclosing Party”) and Forest Laboratories, Inc. (“Receiving Party”).
RESTRICTED STOCK AGREEMENT UNDER THE CLINICAL DATA, INC. AMENDED AND RESTATED 2005 EQUITY INCENTIVE PLANRestricted Stock Agreement • March 8th, 2011 • Clinical Data Inc • Pharmaceutical preparations • Delaware
This Restricted Stock Agreement is between Clinical Data, Inc., a Delaware corporation (the “Company”), and you, the Grantee named above.
NON-DISCLOSURE AGREEMENTNon-Disclosure Agreement • March 8th, 2011 • Clinical Data Inc • Pharmaceutical preparations • Massachusetts
THIS NON-DISCLOSURE AGREEMENT is made as of this 11th day of December 2007, in connection with your consideration of a possible transaction (the “Transaction”) by and between CLINICAL DATA, INC., a Delaware corporation with an office located at One Gateway Center, Suite 702, Newton, Massachusetts 02458 (“Disclosing Party”), and FOREST LABORATORIES, INC., a Delaware Corporation with an office located at 909 Third Avenue, New York, New York 10022 (“Receiving Party”). In consideration of the mutual promises and covenants contained in this Agreement, and the disclosure of confidential information by the Disclosing Party to the Receiving Party for purposes of evaluating a possible transaction between the Disclosing Party and the Receiving Party (a “Transaction”), the parties hereto, intending to be legally bound, hereby agree as follows:
